Who is Olusehunde Elijah Kolawole? Olusehinde Elijah Kolawole is not just a name but a symbol of groundbreaking innovation in the African digital realm.
Medical Expert Predicts Further Rise in COVID-19 in January thisdaylive.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from thisdaylive.com Daily Mail and Mail on Sunday newspapers.
Professor Moji Adeyeye
The National Agency for Food and Drug Administration and Control (NAFDAC) has ruled out the possibility of conducting a local clinical trial on the proposed N400bn vaccines before administering them on Nigerians.
The agency said since the World Health Organisation had approved the vaccines there might not be need to conduct another clinical trial on the vaccines.
It, however, said it would subject vaccines, which the Federal Government may likely spend N400bn to procure, to proper revalidation before administering them on Nigerians.
Speaking at the weekend, NAFDAC’s Media Consultant, Sayo Akintola, stated that owing to the exigencies of COVID-19, there may be no reason to conduct a trial before administering the vaccines.
COVID-19 vaccine: NAFDAC rules out clinical trial
• Reps set to revisit bill mandating vaccines for Nigerians
• FG places six-month ban on 100 travellers for shunning PCR test
• Bayelsa, Ebonyi postpone school resumption, Rivers resumes Monday
Our Reporters
The National Agency for Food and Drug Administration and Control has ruled out the possibility of conducting a local clinical trial on the proposed N400bn vaccines before administering them on Nigerians.
The agency said since the World Health Organisation had approved the vaccines there might not be need to conduct another clinical trial on the vaccines.
It, however, said it would subject vaccines, which the Federal Government may likely spend N400bn to procure, to proper revalidation before administering them on Nigerians.